Individual Differences of Multipotent Mesenchymal Stromal Cells Manifesting in during Interaction with Lymphocytes
- Авторы: Kapranov N.1, Davydova Y.1, Gal’tseva I.1, Petinati N.1, Sats N.1, Drize N.1, Kuz’mina L.1, Parovichnikova E.1, Savchenko V.1
-
Учреждения:
- National Research Center for Hematology, Ministry of Health of the Russian Federation
- Выпуск: Том 165, № 4 (2018)
- Страницы: 584-588
- Раздел: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/240574
- DOI: https://doi.org/10.1007/s10517-018-4218-3
- ID: 240574
Цитировать
Аннотация
Analysis of changes in lymphocyte subpopulations during co-culturing with multipotent mesenchymal stromal cells (MSC) revealed two distinct MSC groups: one group (A) increased HLA-DR expression on lymphocytes during co-culturing and the other (B) did not change it in comparison with lymphocyte monoculture. In stromal cells interacting with lymphocytes, expression of HLA-DR molecules was initiated, but only in samples that induced enhanced expression on lymphocytes and irrespectively of whether allogeneic or autologous lymphocytes were used for co-culturing with MSC. In group A, the relative expression of IDO1 significantly increased in comparison with group B. The revealed individual differences in MSC can explain why not all MSC samples are effective in the treatment of autoimmune diseases, acute “graft—versus—host” disease, and other pathologies.
Об авторах
N. Kapranov
National Research Center for Hematology, Ministry of Health of the Russian Federation
Email: ndrize@yandex.ru
Россия, Moscow
Yu. Davydova
National Research Center for Hematology, Ministry of Health of the Russian Federation
Email: ndrize@yandex.ru
Россия, Moscow
I. Gal’tseva
National Research Center for Hematology, Ministry of Health of the Russian Federation
Email: ndrize@yandex.ru
Россия, Moscow
N. Petinati
National Research Center for Hematology, Ministry of Health of the Russian Federation
Email: ndrize@yandex.ru
Россия, Moscow
N. Sats
National Research Center for Hematology, Ministry of Health of the Russian Federation
Email: ndrize@yandex.ru
Россия, Moscow
N. Drize
National Research Center for Hematology, Ministry of Health of the Russian Federation
Автор, ответственный за переписку.
Email: ndrize@yandex.ru
Россия, Moscow
L. Kuz’mina
National Research Center for Hematology, Ministry of Health of the Russian Federation
Email: ndrize@yandex.ru
Россия, Moscow
E. Parovichnikova
National Research Center for Hematology, Ministry of Health of the Russian Federation
Email: ndrize@yandex.ru
Россия, Moscow
V. Savchenko
National Research Center for Hematology, Ministry of Health of the Russian Federation
Email: ndrize@yandex.ru
Россия, Moscow
![](/img/style/loading.gif)